首页> 外国专利> Concentration of iron in blood and changes within GPX1 gene as risk factors for cancers in women

Concentration of iron in blood and changes within GPX1 gene as risk factors for cancers in women

机译:血液中铁的浓度和GPX1基因内的变化是女性癌症的危险因素

摘要

in the notification, it was found that there is a correlation between genotype gpx1 gene (rs1050450), iron levels in serum and the risk of cancers in women in poland. the object of the application is how to determine the risk of cancer.way is characterized by the fact that includes assessment of the constitutional changes in gene gpx1 pro200leu (rs 1050450) and assessment of iron levels in biological test sample womenwith the combination of individual genotypes with fixed iron concentration indicates significantly reduced risk for cancers: - development gpx1 cc genotype at the concentration of iron in serum of 1050 - 1350 mcg / l (or concentration in any biological material corresponding to the concentration in the serum); - for genotype gpx1 ncc at the concentration of iron in serum 725 - 900 mcg / l (or concentration in any biological material frompowiadaju0105cym concentration in serum).
机译:在该通知中,发现基因型gpx1基因(rs1050450),血清铁水平和波兰妇女患癌症的风险之间存在相关性。本申请的目的是如何确定癌症的风险。way的特点是包括评估基因gpx1 pro200leu(rs 1050450)的体质变化以及结合个体基因型评估生物学测试样本女性中的铁水平具有固定的铁浓度表明明显降低了患癌症的风险:-在血清铁浓度为1050-1350 mcg / l(或与血清中浓度相对应的任何生物材料中的浓度)下发展gpx1 cc基因型; -对于基因型gpx1 ncc,血清中铁的浓度为725-900 mcg / l(或血清中任何生物材料中的浓度)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号